dihexa cancer risk hgf c-met Frontiers Targeting cancer-associated fibroblast-activated HGF/c-MET pathway
Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect dihexa cancer risk hgf c met Signaling pathway of HGF c MET in cancers. Stimulation of by Dihexa Peptide: Benefits, Mechanism, and Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link Role of the HGF c MET tyrosine kinase inhibitors in metastasic melanoma Molecular Cancer Springer Nature Link Recent Progress and Advances in HGF MET Targeted Therapeutic Agents for Cancer Treatment
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




